Bicycolol tablets in treatment of patients with YMDD mutations of HBV

( views:, downloads: )
WANG Jun-wei(Department of Infectious Diseases,Tiantai Hospital,Taizhou 317200,China)
BAI Xue-ling()
RUAN Bing()
Journal Title:
Volume 2, Issue 04, 2009
Key Word:
Hepatitis B virus;Bicyclol;YMDD mutation

Abstract: Objective To evaluate the clinical efficacy and safety of bicyelol tablets in treatment of hepatitis B patients infected with YMDD mutation of HBV. Methods Sixty-eight chronic hepatitis patients infected with HBV YMDD mutants and 100 patients with non-mutants HBV were enrolled in the study. All patients received bicyclol tablets orally 150 mg/d, t. i. d, for 24 weeks. Clinical symptoms, signs and adverse effects were observed, and the blood routine, liver function tests, serum HBV markers and HBV DNA loads were examined at 12th and 24th week of the study, Results After treatment for 24 weeks, the normalization rates of ALT and AST in mutant group were 79.4% ( 54/68 ) and 70. 6% (48/68) ; 11 ( 16. 2% ) patients were markedly effective and 14 (20. 6% ) were effective. Clearance rates of HBeAg and HBV DNA were 27.9% ( 17/61 ) and 17.6% ( 12/68 ), while the seroconversion rate of HBeAg was 14. 7% (9/61). The differences of the above indexes were not statistically significant between mutant group and non-mutant group. Conclusion Bicyciol can both protect liver functions and inhibit virus replication in patients infected with HBV YMDD mutants.

  • [1]Zhu M,Yao GB,Qian YH.Efficacy of long-term lamivudine therapy after emergence of YMDD mutation in chronic hepatitis B.Ganzang,2002,7(2):82-86.(in Chinese)朱玫,姚光弼,钱又宏.慢性乙型肝炎病人出现YMDD变异后继续长期应用拉米夫定的疗效.肝脏,2002,7(2):82-86.
  • [2]Liu GT,Zhang CZ,Li Y,et al.Clinical and pharmacological study of bicyclol-a potential anti-chronic viral hepatitis drug.Chin Med Sci,1999,14(Suppl):51-53.
  • [3]Chinese Society of Infectious Diseases and Parasitology and Chinese Society of Hepatology of Chinese Medical Association.The progamme of prevention and cure for viral hepatitis.Zhonghua Ganzang,bing Zazhi,2000,8(6):324-329.(in Chinese)中华医学会传染病与寄生虫病学分会、肝病学分会.病毒性肝炎防治方案.中华肝脏病杂志,2000,8(6):324-329.
  • [4]Yu ZJ,Jiang HQ,Kan QC,et al.Dynamically analyzing on the anti-virus and hepatoproteetive effects of bicyclol.Zhongguo Yaoye,2003,12(8):27-28.(in Chinese)余祖江,江河清,阚全程,等.双环醇抗病毒与保护肝细胞作用的动态观察和分析.中国药业,2003,12(8):27-28.
  • [5]Yao GB,Xu DZ,Lan P,et al.Efficacy and safety of bicyclol in treatment of 2200 chronic viral hepatitis.Zhongguo Xinyao yu Linchuang Zazhi,2005,24(6):421-426.(in Chinese)姚光弼,徐道振兰培,等.双环醇片治疗2200例慢性病毒性肝炎的安全性和疗效分析.中国新药与临床杂志,2005,24(6):421-426.
  • [6]Ruan B,Wang JW,Bai XL.Comparison of bicycolol therapy for patients with genotype B and C of hepatitis B virus.Zhongguo Shiyan yu Linchuang Bingduxue Zazhi,2007,21 (4):366-368.(in Chinese)阮冰,王军伟,白雪玲.双环醇片对乙型肝炎病毒B、C基因型感染的疗效比较.中华实验与临床病毒学杂志,2007,21(4):366-368.
  • [7]Shen L,Zhao W,Fang ZX,et al.Clinical analysis of treating chronic hepatitis B with bicycolol.Shijie Ganran Zazhi,2006,6(1):67-69.(in Chinese)沈玲,赵伟,方之勋,等.双环醇治疗慢性乙型肝炎临床研究.世界感染杂志,2006,6(1):67-69.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615